Orion Group Interim Report 1–3/2023
ORION CORPORATION INTERIM REPORT 1–3/2023 27 APRIL 2023 at 12:00 EEST Orion Group Interim Report 1–3/2023 This…
Month: April 2023
Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Martinsried/Munich, April 27, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
Prof. Roger Schibli, Head of the Center for Radiopharmaceutical Science at PSI Paul Scherrer Institute…
The St. Joe Company Reports First Quarter 2023 Results and Declares a Quarterly Dividend Of $0.10
Highlights for the first quarter of 2023 compared to the first quarter of 2022: Quarterly…
Junshi Biosciences Announces Primary Endpoint Met in RENOTORCH Study of Toripalimab for 1st-line Treatment of Advanced Renal Cell Carcinoma
SHANGHAI, China, April 27, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data as Oral Presentations at the Global Hepatitis Summit 2023
Seven patients with cHBV remain off all treatment and continue to maintain low levels of…
LoRaWAN® Leads the Global Industrial Evolution and Drives Industry 5.0’s Sustainability, Efficiency and Quality of Life Priorities
LoRaWAN® Industry 5.0 LoRaWAN® drives Industry 5.0’s sustainability, efficiency, and quality of life priorities globally….
Bardeen.ai Announces the Launch of its Revolutionary AI Automation Platform
Harnessing the transformative power of generative AI for modern workplaces with integrations for ChatGPT, Google…
Image Relay Launches Marketing Delivery to Uniquely Combine Digital Asset Management with Product Information Management
The Marketing Delivery platform eliminates the inefficiency, inaccuracy, and chaos of managing digital assets and…
United Rentals Announces Record First Quarter Results and Reaffirms Its Full-Year 2023 Guidance
STAMFORD, Conn.–(BUSINESS WIRE)–United Rentals, Inc. (NYSE: URI) today announced financial results for the first quarter…
Griffon Corporation Schedules Conference Call To Discuss Second Quarter 2023 Financial Results
NEW YORK–(BUSINESS WIRE)–Griffon Corporation (“Griffon” or the “Company”) (NYSE: GFF) today announced it will release…
Element Solutions Inc Announces 2023 First Quarter Financial Results
Net sales of $574 million, a decrease of 16% from the first quarter last year…
Annaly Capital Management, Inc. Reports 1st Quarter 2023 Results
NEW YORK–(BUSINESS WIRE)–Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) today announced its…
The Infinigate Group Announces a New Brand for the Next Era of Expansion
Rotkreuz, Switzerland: 27/04/23. The Infinigate Group, the value-add distributor of cybersecurity, secure networks and secure…
Infinigate Cloud – the EMEA Cybersecurity Distribution Powerhouse’s Expert Business Unit for Secure Cloud Solutions
Fareham, UK: 27/04/23. Vuzion, an Infinigate Group company, is rebranding to Infinigate Cloud, fulfilling the…
Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
BERKELEY, Calif. and MAINZ, Germany, April 27, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ)…
Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
BERKELEY, Calif. and MAINZ, Germany, April 27, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ)…
Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry
PRESS RELEASE Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative…
Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry
PRESS RELEASE Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative…
Mendus to participate in upcoming conferences in May 2023
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…